(Q34084402)

30 July 2017

title

Syntheses and evaluation of halogenated cytisine derivatives and of bioisosteric thiocytisine as potent and selective nAChR ligands (English)

1 reference

30 July 2017

P Imming

1

1 reference

30 July 2017

P Klaperski

2

1 reference

30 July 2017

M T Stubbs

3

1 reference

30 July 2017

G Seitz

4

1 reference

30 July 2017

D Gündisch

5

1 reference

30 July 2017

publication date

1 April 2001

1 reference

European Journal of Medicinal Chemistry

30 July 2017

published in

1 reference

30 July 2017

volume

36

1 reference

30 July 2017

issue

4

1 reference

30 July 2017

page(s)

375-388

1 reference

Preface (Festschrift david De wied)

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2801%2901222-3

7 January 2021

Neuronal nicotinic acetylcholine receptors as targets for drug discovery

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2801%2901222-3

7 January 2021

Central nicotinic receptor agonists ABT-418, ABT-089, and (-)-nicotine reduce distractibility in adult monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2801%2901222-3

7 January 2021

Antinociceptive profile of the new nicotinic agonist DBO-83

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2801%2901222-3

7 January 2021

AR-R17779, and alpha7 nicotinic agonist, improves learning and memory in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2801%2901222-3

7 January 2021

Synthesis and nicotinic activity of epiboxidine: an isoxazole analogue of epibatidine

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2801%2901222-3

7 January 2021

Broad-spectrum, non-opioid analgesic activity by selective modulation of neuronal nicotinic acetylcholine receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2801%2901222-3

7 January 2021

2-, 5-, and 6-Halo-3-(2(S)-azetidinylmethoxy)pyridines: synthesis, affinity for nicotinic acetylcholine receptors, and molecular modeling

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2801%2901222-3

7 January 2021

Alteration in nicotine binding sites in Parkinson's disease, Lewy body dementia and Alzheimer's disease: possible index of early neuropathology

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2801%2901222-3

7 January 2021

Nicotinic receptor binding of [3H]cytisine, [3H]nicotine and [3H]methylcarbamylcholine in rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2801%2901222-3

7 January 2021

Characterization of [3H]cytisine binding to human brain membrane preparations

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2801%2901222-3

7 January 2021

Binding of Quinolizidine Alkaloids to Nicotinic and Muscarinic Acetylcholine Receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2801%2901222-3

7 January 2021

The comparative binding characteristics of nicotinic ligands and their pharmacology.

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2801%2901222-3

7 January 2021

Synthesis and preliminary pharmacological evaluation of some cytisine derivatives

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2801%2901222-3

7 January 2021

exo-2-(Pyridazin-4-yl)-7-azabicyclo[2.2.1]heptanes: syntheses and nicotinic acetylcholine receptor agonist activity of potent pyridazine analogues of (+/-)-epibatidine.

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2801%2901222-3

7 January 2021

5-Iodo-A-85380, an alpha4beta2 subtype-selective ligand for nicotinic acetylcholine receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2801%2901222-3

7 January 2021

Bioisosterism: A Rational Approach in Drug Design

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2801%2901222-3

7 January 2021

Synthesis of analogues of (-)-cytisine for in vivo studies of nicotinic receptors using positron emission tomography

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2801%2901222-3

7 January 2021

High affinity binding of [3H]epibatidine to rat brain membranes

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2801%2901222-3

7 January 2021

Characterisation of the binding of [3H]methyllycaconitine: a new radioligand for labelling alpha 7-type neuronal nicotinic acetylcholine receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2801%2901222-3

7 January 2021

Total synthesis of (+/-)-cytisine

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2801%2901222-3

7 January 2021

Total synthesis of (+/-)-cytisine via the intramolecular heck cyclization of activated N-alkyl glutarimides

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2801%2901222-3

7 January 2021

Microwave-accelerated solvent-free synthesis of thioketones, thiolactones, thioamides, thionoesters, and thioflavonoids

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2801%2901222-3

7 January 2021

Solvent Effects on the Barrier to Rotation in Carbamates

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2801%2901222-3

7 January 2021

The ensemble approach to distance geometry: application to the nicotinic pharmacophore

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2801%2901222-3

7 January 2021

[Bromine-derivatives of cytisine]

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2801%2901222-3

7 January 2021

Completion and refinement of crystal structures withSIR92

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2801%2901222-3

7 January 2021

Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2801%2901222-3

7 January 2021

10.1016/S0223-5234(01)01222-3

Identifiers

DOI

1 reference

30 July 2017

1 reference